Trial Profile
A Phase I, Open Label Study to Assess the Effects of TA-8995 on the Pharmacokinetics of Midazolam and Digoxin in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Obicetrapib (Primary) ; Digoxin; Midazolam
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Xention
- 20 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2014 New trial record